Literature DB >> 32319850

Why We Think Laparoscopic Sleeve Gastrectomy Is a Good Operation: Step-by-Step Technique.

Mariano Palermo1, Michel Gagner2.   

Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed bariatric procedure in the world, with 75% of the primary procedures performed in the United States. It is a safe and effective primary bariatric procedure with good weight loss. When comparing with other procedures, LSG is limited to the stomach, avoiding the presence of internal hernias, preserving the pyloric anatomy, with normal gastric emptying, and conveying less severe rebound hypoglycemia. Materials and
Methods: We describe the technique, step-by-step, we use to perform a sleeve gastrectomy (SG) and analyze why we think it is a good surgery.
Results: The highlights of a safer SG systematization are based on minimum 36F bougie calibration, starting 4-5 cm from the pylorus, keeping ∼1 cm distance from esophagus. We routinely use staple line reinforcement by continuous suture. Comparing with Roux-en-Y gastric bypass, less bowel obstruction, less dumping syndromes, less hypoglycemia, and also less ulcers are described.
Conclusion: LSG is a safe and effective primary bariatric procedure with durable weight loss. And when comparing with others with intestinal anastomosis, we found fewer complications such as less internal hernias, access to the bile duct after surgery, and has the great advantage that it can be revised when it fails.

Entities:  

Keywords:  bariatric surgery; complications; laparoscopy; obesity; sleeve gastrectomy

Mesh:

Year:  2020        PMID: 32319850     DOI: 10.1089/lap.2020.0154

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  1 in total

1.  Staple Line Reinforcement During Laparoscopic Sleeve Gastrectomy: Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

Authors:  Alberto Aiolfi; Michel Gagner; Marco Antonio Zappa; Caterina Lastraioli; Francesca Lombardo; Valerio Panizzo; Gianluca Bonitta; Marta Cavalli; Giampiero Campanelli; Davide Bona
Journal:  Obes Surg       Date:  2022-02-16       Impact factor: 3.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.